Increased liability of tramadol–warfarin interaction in individuals with mutations in the cytochrome P ₄₅₀ 2D6 gene

By Hedenmalm Karin   Lindh Jonatan   Säwe Juliette   Rane Anders  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 5, 2004-07 ,pp. : 369-372

Springer Publishing Company

Access to resources Recommend Favorite

Genetic variations in cytochrome P450 (CYP) 2D6 activity may have important clinical consequences for some drugs

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 5, 2010-05 ,pp. : 21-26

Adis International

Access to resources Recommend Favorite

Genetic Polymorphism in Cytochrome P450 2D6 (CYP2D6): Population Distribution of CYP2D6 Activity

By Neafsey Patricia  

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 12, Iss. 5-6, 2009-05 ,pp. : 334-361

Taylor & Francis Ltd

Access to resources Recommend Favorite

An Evaluation of Ondansetron Binding Interactions with Human Cytochrome P450 Enzymes CYP3A4 and CYP2D6

By  

Drug Metabolism Letters, Vol. 4, Iss. 1, 2010-01 ,pp. : 25-30

Bentham Science Publishers

Access to resources Recommend Favorite

Bupropion [amfebutamone] sustained-release (SR) is a potent inhibitor of cytochrome P450 (CYP)2D6

By  

Reactions Weekly, Vol. 1, Iss. 1063, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite